Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Genotropin Dosing Strategies in Idiopathic Short Stature
NCT00396097Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2006
- Primary completion
- Aug 2012
- Modality
- Hormone, rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of genotropin miniquick in Idiopathic Short Stature (ISS), sponsored by Pfizer. Started Dec 2006; status: completed.
02
Drugs
genotropin miniquick
03
Conditions
Idiopathic Short Stature (ISS)
Beyond the preview
Go deeper on NCT00396097.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00396097.